Sun et al. [8] discovered that PSMD14 increases the growth of ovarian cancer by reducing pyruvate kinase activity by inhibiting the deubiquitination of the pyruvate kinase M2 isoform (PKM2). Here, PKM is linked to ovarian carcinoma.